Structural and physiological neurovascular changes in idiopathic Parkinson’s disease and its clinical phenotypes

Sarah Al-Bachari, Rishma Vidyasagar, Hedley Emsley, Laura Parkes

Research output: Contribution to journalArticlepeer-review

Abstract

Neurovascular changes are likely to interact importantly with the neurodegenerative process in idiopathic Parkinson’s disease (IPD). Markers of neurovascular status (NVS) include white matter lesion (WML) burden and arterial spin labelling (ASL) measurements of cerebral blood flow (CBF) and arterial arrival time (AAT). We investigated NVS in IPD, including an analysis of IPD clinical phenotypes, by comparison with two control groups, one with a history of clinical cerebrovascular disease (CVD) (control positive, CP) and one without CVD (control negative, CN). Fifty-one patients with IPD (mean age 69.0 ± 7.7 years) (21 tremor dominant (TD), 24 postural instability and gait disorder (PIGD) and six intermediates), 18 CP (mean age 70.1 ± 8.0 years) and 34 CN subjects (mean age 67.4 ± 7.6 years) completed a 3T MRI scan protocol including T2-weighted fluid-attenuated inversion recovery (FLAIR) and ASL. IPD patients showed diffuse regions of significantly prolonged AAT, small regions of lower CBF and greater WML burden by comparison with CN subjects. TD patients showed lower WML volume by comparison with PIGD patients. These imaging data thus show altered NVS in IPD, with some evidence for IPD phenotype-specific differences.
Original languageEnglish
Pages (from-to)3409-3421
Number of pages13
JournalJournal of Cerebral Blood Flow and Metabolism
Volume37
Issue number10
Early online date23 Jan 2017
DOIs
Publication statusPublished - 1 Oct 2017

Keywords

  • Magnetic resonance imaging
  • arterial spin labelling
  • Cerebral blood flow
  • Parkinson's disease
  • Cerebrovascular disease

Research Beacons, Institutes and Platforms

  • Manchester Institute for Collaborative Research on Ageing

Fingerprint

Dive into the research topics of 'Structural and physiological neurovascular changes in idiopathic Parkinson’s disease and its clinical phenotypes'. Together they form a unique fingerprint.

Cite this